{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:16:20Z","timestamp":1790039780947,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T00:00:00Z","timestamp":1439251200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1013-x","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T06:45:13Z","timestamp":1439189113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance"],"prefix":"10.1186","volume":"15","author":[{"name":"The Euro-GASP Network","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Spiteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Grigorjev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,11]]},"reference":[{"key":"1013_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/jac\/dkt017","volume":"68","author":"Y Chen","year":"2013","unstructured":"Chen Y, Stevens K, Tideman R, Zaia A, Tomita T, Fairley CK, et al. Failure of 500\u00a0mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia. J Antimicrob Chemother. 2013;68:1445\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"1013_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27:587\u2013613.","journal-title":"Clin Microbiol Rev."},{"key":"1013_CR3","doi-asserted-by":"crossref","unstructured":"Golparian D, Ohlsson A, Janson H, Lidbrink P, Richtner T, Ekelund O, et al. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500\u00a0mg) or cefotaxime (500\u00a0mg), Sweden, 2013 and 2014. Euro Surveill. 2014;19.","DOI":"10.2807\/1560-7917.ES2014.19.30.20862"},{"key":"1013_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/jac\/dkt034","volume":"68","author":"DA Lewis","year":"2013","unstructured":"Lewis DA, Sriruttan C, Muller EE, Golparian D, Gumede L, Fick D, et al. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother. 2013;68:1267\u201370.","journal-title":"J Antimicrob Chemother."},{"key":"1013_CR5","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Potocnik M, Jeverica S. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill. 2012;17.","DOI":"10.2807\/ese.17.25.20200-en"},{"key":"1013_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56:1273\u201380.","journal-title":"Antimicrob Agents Chemother."},{"key":"1013_CR7","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Stary A, Eigentler A. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill. 2011;16.","DOI":"10.2807\/ese.16.43.19998-en"},{"key":"1013_CR8","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill. 2010;15.","DOI":"10.2807\/ese.15.47.19721-en"},{"key":"1013_CR9","doi-asserted-by":"crossref","unstructured":"Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance toceftriaxone. Antimicrob Agents Chemother. 2011;55:3538\u201345.","DOI":"10.1128\/AAC.00325-11"},{"key":"1013_CR10","doi-asserted-by":"crossref","unstructured":"Ison CA, Hussey J, Sankar KN, Evans J, Alexander S. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill. 2011;16.","DOI":"10.2807\/ese.16.14.19833-en"},{"key":"1013_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1258\/ijsa.2009.009191","volume":"22","author":"S Forsyth","year":"2011","unstructured":"Forsyth S, Penney P, Rooney G. Cefixime-resistant Neisseria gonorrhoeae in the UK: a time to reflect on practice and recommendations. Int J STD AIDS. 2011;22:296\u20137.","journal-title":"Int J STD AIDS."},{"key":"1013_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2012.176575","volume":"309","author":"VG Allen","year":"2013","unstructured":"Allen VG, Mitterni L, Seah C, Rebbapragada A, Martin IE, Lee C, et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA. 2013;309:163\u201370.","journal-title":"JAMA."},{"key":"1013_CR13","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill. 2011;16.","DOI":"10.2807\/ese.16.06.19792-en"},{"key":"1013_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1071\/SH13077","volume":"10","author":"PJ Read","year":"2013","unstructured":"Read PJ, Limnios EA, McNulty A, Whiley D, Lahra MM. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500\u00a0mg ceftriaxone in Sydney, Australia. Sex Health. 2013;10:460\u20132.","journal-title":"Sex Health"},{"issue":"Suppl 4","key":"1013_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/sextrans-2013-051162","volume":"89","author":"RD Kirkcaldy","year":"2013","unstructured":"Kirkcaldy RD, Kidd S, Weinstock HS, Papp JR, Bolan GA. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012. Sex Transm Infect. 2013;89 Suppl 4:5\u201310.","journal-title":"Sex Transm Infect"},{"key":"1013_CR16","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.14745\/ccdr.v41i02a04","volume":"41","author":"I Martin","year":"2015","unstructured":"Martin I, Sawatzky P, Liu G, Mulvey MR. Antimicrobial resistance to Neisseria gonorrhoeae in Canada: 2009\u20132013. CCDR. 2015;41:S4. http:\/\/www.phac-aspc.gc.ca\/publicat\/ccdr-rmtc\/15vol41\/dr-rm41-02\/surv-4-eng.php (Accessed: June 14, 2015).","journal-title":"CCDR"},{"key":"1013_CR17","unstructured":"European Centre for Disease Prevention and Control. ECDC SURVEILLANCE REPORT: Sexually Transmitted Infections in Europe 2012 . 2014. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/sexually-transmitted-infections-europe-surveillance-report-2012.pdf (Accessed: June 14, 2015)."},{"key":"1013_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/infdis\/jis298","volume":"206","author":"K Mlisana","year":"2012","unstructured":"Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012;206:6\u201314.","journal-title":"J Infect Dis."},{"key":"1013_CR19","first-page":"1868","volume":"349","author":"MS Cohen","year":"1997","unstructured":"Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group Lancet. 1997;349:1868\u201373.","journal-title":"AIDSCAP Malawi Research Group. Lancet."},{"key":"1013_CR20","doi-asserted-by":"crossref","unstructured":"Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Non-ulcerative sexually transmitted diseases as riskfactors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993;7(1):95\u2013102.","DOI":"10.1097\/00002030-199301000-00015"},{"key":"1013_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/sextrans-2012-050674","volume":"88","author":"F Ndowa","year":"2012","unstructured":"Ndowa F, Lusti-Narasimhan M, Unemo M. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex Transm Infect. 2012;88:317\u20138.","journal-title":"Sex Transm Infect."},{"key":"1013_CR22","unstructured":"World Health Organisation. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. 2012. http:\/\/whqlibdoc.who.int\/publications\/2012\/9789241503501_eng.pdf (Accessed: June 14, 2015)."},{"key":"1013_CR23","unstructured":"Centers for Disease Control and Prevention. Cephalosprin-resistant Neisseria gonorrhoeae Public Health Response Plan. 2012. http:\/\/www.cdc.gov\/std\/treatment\/ceph-r-responseplanjuly30-2012.pdf (Accessed: June 14, 2015)."},{"key":"1013_CR24","unstructured":"European Centre for Disease Prevention and Control. Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe. Stockholm: ECDC; 2012. 2012. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/1206-ECDC-MDR-gonorrhoea-response-plan.pdf (Accessed: June 14, 2015)."},{"key":"1013_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462412472837","volume":"24","author":"C Bignell","year":"2013","unstructured":"Bignell C, Unemo M. On behalf of the European STI Guidelines Editorial Board. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013;24:85\u201392.","journal-title":"Int J STD AIDS"},{"key":"1013_CR26","unstructured":"UK AMR High Level Steering Group. UK 5 Year Antimicrobial Resistance (AMR) Strategy 2013\u20132018. 2014. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/322358\/Outcome_measures.pdf (Accessed: June 14, 2015)."},{"key":"1013_CR27","unstructured":"World Health Organisation. Antimicrobial resistance: global report on surveillance. 2014. http:\/\/apps.who.int\/iris\/bitstream\/10665\/112642\/1\/9789241564748_eng.pdf (Accessed: June 14, 2015)."},{"key":"1013_CR28","unstructured":"Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. 2013. http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf (Accessed: June 14, 2015)."},{"key":"1013_CR29","unstructured":"European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe 2012. 2014. http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/gonococcal-antimicrobial-susceptibility-surveillance-Europe-2012.pdf (Accessed: June 14, 2015)."},{"key":"1013_CR30","doi-asserted-by":"crossref","unstructured":"Cole M, Spiteri G, Chisholm S, Hoffmann S, Ison C, Unemo M, et al. Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe. Euro Surveill. 2014;19.","DOI":"10.2807\/1560-7917.ES2014.19.45.20955"},{"issue":"4","key":"1013_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/sextrans-2012-050904","volume":"89","author":"M Bala","year":"2013","unstructured":"Bala M, Kakran M, Singh V, Sood S, Ramesh V. Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis. Sex Transm Infect. 2013;89(4):28\u201335.","journal-title":"Sex Transm Infect"},{"key":"1013_CR32","unstructured":"Public Health England. GRASP 2012 Report: The Gonococcal Resistance to Antimicrobials Surveillance Programme. 2013. http:\/\/194.74.226.162\/webc\/HPAwebFile\/HPAweb_C\/1317140152190 (Accessed: June 14, 2015)."},{"key":"1013_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/1471-2334-14-342","volume":"14","author":"A Kubanova","year":"2014","unstructured":"Kubanova A, Kubanov A, Frigo N, Solomka V, Semina V, Vorobyev D, et al. Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009\u20132012 and NG-MAST genotypes in 2011 and 2012. BMC Infect Dis. 2014;14:342.","journal-title":"BMC Infect Dis."},{"key":"1013_CR34","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1473-3099(13)70143-9","volume":"13","author":"CA Ison","year":"2013","unstructured":"Ison CA, Town K, Obi C, Chisholm S, Hughes G, Livermore DM, et al. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007\u20132011. Lancet Infect Dis. 2013;13:762\u20138.","journal-title":"Lancet Infect Dis."},{"key":"1013_CR35","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/jac\/dku026","volume":"69","author":"S Jeverica","year":"2014","unstructured":"Jeverica S, Golparian D, Maticic M, Potocnik M, Mlakar BX, Unemo M. Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006\u201312: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone? J Antimicrob Chemother. 2014;69:1517\u201325.","journal-title":"J Antimicrob Chemother."},{"key":"1013_CR36","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1093\/jac\/dku245","volume":"69","author":"SC Chen","year":"2014","unstructured":"Chen SC, Yin YP, Dai XQ, Unemo M, Chen XS. Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China. J Antimicrob Chemother. 2014;69:2959\u201365.","journal-title":"J Antimicrob Chemother."},{"key":"1013_CR37","unstructured":"European Committee on Antimicrobial Susceptibility Testing - EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. 2012. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/Breakpoint_table_v_2.0_120221.pdf (Accessed: June 14, 2015)."},{"key":"1013_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1258\/ijsa.2011.011267","volume":"22","author":"C Bignell","year":"2011","unstructured":"Bignell C, Fitzgerald M. UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS. 2011;22:541\u20137.","journal-title":"Int J STD AIDS."},{"issue":"RR-03","key":"1013_CR39","first-page":"1","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1\u2013137.","journal-title":"MMWR Recomm Rep"},{"key":"1013_CR40","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/OLQ.0000000000000185","volume":"41","author":"MJ Cole","year":"2014","unstructured":"Cole MJ, Spiteri G, Town K, Unemo M, Hoffmann S, Chisholm SA, et al. Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe. Sex Transm Dis. 2014;41:723\u20139.","journal-title":"Sex Transm Dis."},{"issue":"Suppl 4","key":"1013_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/sextrans-2013-051395","volume":"89","author":"FJ Ndowa","year":"2013","unstructured":"Ndowa FJ, Ison CA, Cole MJ, Lusti-Narasimhan M. Gonococcal antimicrobial resistance: challenges for public health control. Sex Transm Infect. 2013;89 Suppl 4:3\u20134.","journal-title":"Sex Transm Infect"},{"key":"1013_CR42","unstructured":"European Centre for Disease Prevention and Control. ECDC SURVEILLANCE REPORT: Sexually Transmitted Infections in Europe 2013. 2015. (In press)."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-1013-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1013-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:04:56Z","timestamp":1653005096000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1013-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1013"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1013-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,11]]},"article-number":"321"}}